• OUR FOCUS
  • OUR PIPELINE
  • OUR TEAM
  • INVESTORS
  • NEWS
  • CONTACT US
Linkedin Twitter
  • OUR FOCUS
  • OUR PIPELINE
  • OUR TEAM
  • INVESTORS
  • NEWS
  • CONTACT US
  • OUR FOCUS
  • OUR PIPELINE
  • OUR TEAM
  • INVESTORS
  • NEWS
  • CONTACT US

news

Press releases

24th December 2021

Alterola Biotech Inc. announces the execution of a Memorandum of Understanding (MoU) with Averix Bio LLC.

15th November 2021

Alterola Biotech Inc. confirms the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.

12th November 2021

Alterola Biotech Inc. Registration Statement Declared Effective

18th October 2021

Alterola Biotech Inc. Issues Statement About Promotional Activity Concerning Its Common Stock

15th October 2021

Alterola Biotech Inc. Issues Statement About Promotional Activity Concerning Its Common Stock

23rd September 2021

Alterola Biotech Inc. Confirms Key Executive Appointment Joining the Board

13th July 2021

ALTEROLA BIOTECH INC. ACQUIRES ABTI PHARMA LTD

speech bubbleAsset 1

Our Company

  • Our Focus
  • Our Pipeline
  • Our Team
  • Investors

Useful Links

  • Careers
  • Latest News
  • Contact Us
Linkedin Twitter
  • info@phytanix.com

ÂĐ 2024 Phytanix Bio. All right reserved. Website by Rhino Websites